A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy
Open accessThe DOI matches its Crossref record; 26 of the 29 references it cites were found in a registry or an index.
Abstract
In Brief Objective: To compare outcomes with early corticosteroid withdrawal (CSWD) and chronic low dose corticosteroid therapy (CCS). Summary Background Data: Final, 5-year results from the first randomized, double-blind, placebo-controlled trial of early CSWD (at 7 days posttransplant) are presented. Methods: Adult recipients of deceased and living donor kidney transplants without delayed graft function were randomized to receive prednisone (5 mg/d after 6 months posttransplant) or CSWD. Blinding was maintained for 5 years. This clinical trial is registered at www.clinicaltrials.gov (NCT00650468). Results: Results in 386 patients CSWD (n = 191), CCS (n = 195) are presented (CSWD; CCS). No differences were observed at 5 years in the proportion of patients experiencing: primary end point (composite of death, graft loss, or moderate/severe acute rejection) (30/191 (15.7%); 28/195 (14.4%)), patient death (11/191(5.8%);13/195 (6.7%)), death-censored graft loss (11/191 (5.8%); 7/195(3.6%)), biopsy confirmed acute rejection (BCAR) (34/191 (17.8%); 21/195 (10.8%), P = 0.058), moderate/severe acute rejection (15/191 (7.9%); 12/195 (6.2%)). Kaplan Meier analyses of the primary end point and its components also showed no differences; but BCAR was higher with CSWD (P = 0.04). Increased BCAR episodes were primarily corticosteroid-sensitive Banff 1A rejections: the incidence of antibody-treated BCAR was similar between groups (11/191 (5.8%); 13/195 (6.7%)). No differences in renal function were observed at 5 years: mean serum creatinine (1.5 ± 0.6; 1.5 ± 0.7 mg/dL), or Cockroft Gault calculated creatinine clearance (58.6 ± 19.7; 59.8 ± 20.5 mL/min). CSWD was associated with improved serum triglycerides (evaluated by mean and median change from baseline) at all time points (except at 5 years measured by mean change). Weight change also demonstrated changes favoring CSWD (median change from baseline at 5 years: 5.1 vs. 7.7 kg, P = 0.05). New onset diabetes after transplant (NODAT) was similar with respect to proportions who required treatment (23/107 (21.5%)); 18/86 (20.9%); however, fewer CSWD patients required insulin for NODAT at 5 years (4/107 (3.7%)); 10/86 (11.6%), P = 0.049). Changes in HgA1c values (from baseline) were lower in CSWD patients at all time points except 4 years. Conclusions: Early CSWD, compared with CCS, is associated with an increase in BCAR primarily because of mild, Banff 1A, steroid-sensitive rejection, yet provides similar long-term renal allograft survival and function. CSWD provides improvements in cardiovascular risk factors (triglycerides, NODAT requiring insulin, weight gain). Tacrolimus/MMF/antibody induction therapy allows early CSWD with results comparable to long-term low dose (5 mg/d) prednisone therapy. Final results from the first prospective, randomized, placebo-controlled, double-blind trial of early corticosteroid withdrawal in kidney transplantation are reported. This trial, which was blinded for 5 years, demonstrates that early corticosteroid withdrawal (under induction therapy with tacrolimus/mycophenolate mofetil therapy), as compared to chronic corticosteroid therapy, provides similar patient survival, and renal allograft survival and function. Early corticosteroid withdrawal was associated with increased acute rejection risk, but also provided improvements in several corticosteroid-related morbidities including post-transplant diabetes, weight gain, and triglycerides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other more unique risk factors in this population include genetic polymorphisms, polycystic kidney disease, hepatitis C, and cytomegalovirus status.1579–1581”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1581]
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
The Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
Immunosuppression: Evolution in Practice and Trends, 1994–2004
Meier-Kriesche, H.-U., Li, S., Gruessner, R. W. G., Fung, J. J., Bustami, R. T., Barr, M. L., & Leichtman, A. B. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01270.x · Cited by 559
&NA; (1999) · Transplantation · doi:10.1097/00007890-199912270-00009 · Cited by 277
Rostaing, L., Cantarovich, D., Mourad, G., Budde, K., Rigotti, P., Mariat, C., Margreiter, R., Capdevilla, L., Lang, P., Vialtel, P., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000154915.20524.0a · Cited by 249
Effects of Low-Dose Prednisone on Bone Metabolism
Ton, F. N., Gunawardene, S. C., Lee, H., & Neer, R. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041125 · Cited by 223
Vanrenterghem, Y., Lebranchu, Y., Hen??, R., Oppenheimer, F., & Ekberg, H. (2000) · Transplantation · doi:10.1097/00007890-200011150-00015 · Cited by 213
Sinclair, N. (1992) · Europe PMC (PubMed Central) · Cited by 203
Ratcliffe, P., Dudley, C., Higgins, R., Firth, J., Smith, B., & Morris, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02510-x · Cited by 178
Research works printed but not linked: 2
- Sinclair, 1992, Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts., Can Med Assoc J, 147, 645
- Woodle, 2005, A randomized, prospective, multicenter study of thymoglobulin in renal transplantation for induction and minimization of steroids (TRIMS)., Am J Transplant, 5, 571
Cited by
Items 301–400 of 472
SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review
Kumar, N., Rana, R., Rana, D. S., Gupta, A., & SACHDEVA, M. P. (2022) · Transplantology · doi:10.3390/transplantology3010004 · Cited by 5
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Marcén, R. (2011) · Clinical Investigation · doi:10.4155/cli.11.49 · Cited by 5
Hypertension in renal transplantation
SHARMA, R. K., & Vardhan, H. (2013) · Clinical Queries Nephrology · doi:10.1016/j.cqn.2013.08.002 · Cited by 5
Ekberg, J., Enevoldsen, A.-E. A., Wallquist, C., Skov, K., Jespersen, B., Lindnér, P., & Baid‐Agrawal, S. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.06.016 · Cited by 4
Smith, A. F., Klotz, A., & Wormstone, I. M. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.001 · Cited by 4
Late Steroid Withdrawal Following AB0-Incompatible Renal Transplantation
Bachmann, F., Lachmann, N., Budde, K., Liefeldt, L., Halleck, F., Naik, M. G., Friedersdorff, F., Rudolph, B. D., Wu, K., Meyer, O. G. J., et al. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2017.12.008 · Cited by 4
Early Steroid Withdrawal in Black Transplant Patients: A Selective Process
Augustine, J. J. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11731116 · Cited by 4
Prophylaxis and Treatment of Kidney Transplant Rejection
Wiseman, A. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00100-3 · Cited by 4
Holzner, M. L., Wadhera, V., Basu, A., Florman, S. S., & Shapiro, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53186-3.00017-6 · Cited by 4
Immunosenescence and Immunosuppressive Drugs in the Elderly
Krenzien, F., Hajj, S. E., Tullius, S. G., & Gabardi, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_137 · Cited by 4
Raju, S. B., Dwivedi, R., Shashikiran, K., Manuel, S., Ansari, F. A. I., Madipalli, R. T., & Golla, A. (2022) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_545_20 · Cited by 4
Pernin, V., Głyda, M., Viklický, O., Lõhmus, A., Wennberg, L. M., Witzke, O., von Zur‐Mühlen, B., Anaokar, S., Hurst, M., Kazeem, G., et al. (2023) · Transplantation Direct · doi:10.1097/txd.0000000000001432 · Cited by 4
Hardinger, K. L., Agha, I. A., & Brennan, D. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_3 · Cited by 4
Cantarovich, D., Hodemon-Corne, B., Trébern-Launay, K., Giral, M., Foucher, Y., & Dantan, É. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.10.055 · Cited by 4
Sureshkumar, K. K., Hussain, S. M., Thai, N. L., Ko, T. Y., Nashar, K., & Marcus, R. J. (2014) · World Journal of Transplantation · doi:10.5500/wjt.v4.i3.188 · Cited by 4
Maintenance Steroid Therapy for Kidney Recipients—Not Ready for Relegation
Desaia, N. M., Schnitzler, M. A., Jendrisak, M. D., & Brennan, D. C. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02629.x · Cited by 4
Steroid Withdrawal in Patients Transplanted for IgA Nephropathy—A Disease-Specific Consideration?
Cohney, S. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03668.x · Cited by 4
Are Maintenance Corticosteroids No Longer Necessary after Kidney Transplantation?
Augustine, J. J., & Hricik, D. E. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01020112 · Cited by 4
Turner, L., Vock, D. M., Helgeson, E. S., Kandaswamy, R., Spong, R., Pruett, T. L., Finger, E. B., Humphreville, V., Chinnakotla, S., Adams, A. B., et al. (2025) · Clinical Transplantation · doi:10.1111/ctr.70297 · Cited by 3
Kaijansinkko, H., Tainio, J., Bjerre, A. K., Gjerstad, A. C., Weinreich, I. D., Jalanko, H., Wennberg, L. M., Ladfors, S. W., Thiesson, H. C., Békássy, Z. D., et al. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-07030-7 · Cited by 3
Early Steroid Withdrawal in Kidney Transplant Recipients: PRO
Virmani, S., & Asch, W. S. (2025) · Kidney360 · doi:10.34067/kid.0000000000000326 · Cited by 3
Early Steroid Withdrawal in Kidney Transplant Recipients: CON
Aziz, F., & Parajuli, S. (2025) · Kidney360 · doi:10.34067/kid.0000000000000323 · Cited by 3
Sureshkumar, K. K., Tangirala, B., Marcus, R. J., & Hussain, S. (2013) · Indian Journal of Nephrology · doi:10.4103/0971-4065.120328 · Cited by 3
Kurian, S. M., Bagsic, S. R. S., Case, J., Barrick, B. L., Schaffer, R. L., Rice, J. C., & Marsh, C. L. (2020) · Transplantation Reports · doi:10.1016/j.tpr.2020.100063 · Cited by 3
The Influence of Kidney Disease on Protein and Amino Acid Metabolism
Workeneh, B., & Mitch, W. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00001-1 · Cited by 3
Why do we need biomarkers in solid organ transplantation
Olbricht, C. J. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.04.026 · Cited by 3
Lim, M. A., & Bloom, R. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00038-0 · Cited by 3
Tan, J. C., Busque, S., & Scandling, J. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10072-7 · Cited by 3
Steroid Withdrawal in Kidney Transplantation: The Subgroup Fallacy
Steiner, R. W. (2011) · Transplantation · doi:10.1097/tp.0b013e318208e706 · Cited by 3
Hayes, W. N., Boyle, S., Carroll, A., Böckenhauer, D., & Marks, S. D. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3609-4 · Cited by 3
Lim, M. A., Shee, L. Y., Wong, Z. Y., Wong, W. K., Ng, K. T., Moy, F. M., & Lim, S. K. (2026) · Clinical Transplantation · doi:10.1111/ctr.70519 · Cited by 2
Langsford, D., Steinberg, A. G., & Dwyer, K. M. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0478-2 · Cited by 2
Risks and Benefits of Glucocorticoids in ANCA-Associated Vasculitis
Rodrigues, J. C., & Walsh, M. W. (2017) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-017-0081-z · Cited by 2
Immunosenescence and Immunosuppressive Drugs in the Elderly
Krenzien, F., Hajj, S. E., Tullius, S. G., & Gabardi, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_137-1 · Cited by 2
Early steroid withdrawal: a niche for anti-interleukin 2 receptor monoclonal antibodies?
Hellemans, R., Bosmans, J., & Abramowicz, D. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy053 · Cited by 2
Azathioprine and Mycophenolates
Gaston, R. S., Agarwal, G., & Morris, S. P. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53186-3.00015-2 · Cited by 2
Aslam, N., Nawaz, Z., Mousa, D., Altaweel, A., Ashraf, A., Fahim, A., Khan, T. F. T., & Zahid, R. (2019) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.275484 · Cited by 2
Diagnosis and Therapy of Graft Dysfunction
Pham, P. T., Nast, C. C., Pham, P. T., & Danovitch, G. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00037-6 · Cited by 2
Early Steroid Cessation After Kidney Transplant
Matas, A. J. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2020.6959 · Cited by 2
Osteoporosis in organ transplant patients
Liu, Y., Krez, A. N., & Stein, E. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00052-6 · Cited by 2
Barakat, M. M., Abdulrazzaq, S. B., Alzaghari, L. F., Ramatillah, D. L., Muhammad, R. F., & Elnaem, M. H. (2025) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580251333968 · Cited by 2
The role of rabbit antithymocyte globulin in renal transplantation
Bowman, L. J., Edwards, A. R., & Brennan, D. C. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.946902 · Cited by 2
Early corticosteroid withdrawal regimen in a living donor kidney transplantation program
Bansal, S., Sethi, S., Sharma, R. K., Jain, M. K., Jha, P. K., Ahlawat, R. K., Duggal, R., & Kher, V. (2014) · Indian Journal of Nephrology · doi:10.4103/0971-4065.133004 · Cited by 2
Sizzling Issues in Clinical Renal Transplantation
Rubin, M. F. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09511209 · Cited by 2
Management of Posttransplantation Diabetes Mellitus (PTDM)
Soo, B., & Moon, J. H. (2011) · Korean Journal of Transplantation · doi:10.4285/jkstn.2011.25.1.8 · Cited by 2
Human Leukocyte Antigen Mismatch and Steroid Maintenance in Kidney Transplantation
Chopra, B., & Sureshkumar, K. K. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.10.028 · Cited by 2
Wasilewski, G., Przybyłowski, P., Wilusz, M., Sztefko, K., Janik, Ł., Koc‐Żórawska, E., & Małyszko, J. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.02.059 · Cited by 2
Chronic Renal Transplant Dysfunction
Maxwell, H., & Webb, N. J. A. (2016) · Springer eBooks · doi:10.1007/978-3-662-52972-0_69 · Cited by 2
Steroid withdrawal protocols in Renal Transplantation
Halawa, A. M. (2018) · Archives of Clinical Nephrology · doi:10.17352/acn.000029 · Cited by 2
Propensity score analysis for correlated subgroup effects
Liu, S.-Y., Liu, C., Nehus, E., Macaluso, M., Lü, B., & Kim, M. (2019) · Statistical Methods in Medical Research · doi:10.1177/0962280219850595 · Cited by 2
Pieloch, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-44858-5_18 · Cited by 2
Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review
Naesens, M., Berger, S. P., Biancone, L., Crespo, M., Djamali, A., Hertig, A., Öllinger, R., Portolés, J. M., Zuckermann, A. O., & Pascual, J. (2016) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2016.09.001 · Cited by 2
Schmid‐Mohler, G., Huber, L., & Mueller, T. (2022) · Progress in Transplantation · doi:10.1177/15269248221122891 · Cited by 2
Ko, Y., Wee, Y., Shin, S., Kim, M. J., Choi, M. Y., Kim, D. H., Lim, S. J., Jung, J. H., Kwon, H., Kim, Y. H., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280924 · Cited by 2
Kurian, S. M., Bagsic, S. R. S., Case, J., Barrick, B. L., Schaffer, R. L., Rice, J. C., & Marsh, C. L. (2021) · Transplantation Direct · doi:10.1097/txd.0000000000001196 · Cited by 1
Ordaya, E. E., Shaughnessy, M. K., Elkin, B. R., Husmann, R., Stauffer, J. C., Luengas, E. M., Chang, B. H., Tessier, K., Walker, P. F., & Stauffer, W. M. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14039 · Cited by 1
Kidney transplantation: the recipient
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23571-9.00018-9 · Cited by 1
Post-Kidney Transplantation Hypertension
Roumeliotis, S. K., Mallamaci, F., & Zoccali, C. (2025) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-81292-7_6 · Cited by 1
Use of molecular mismatch to guide induction therapy
Tran, J. N., & Lan, J. H. (2025) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001254 · Cited by 1
The Exposome Era in Kidney Transplantation: A New Frontier in Graft Outcomes and Precision Medicine
Güldan, M., Al-Shiab, R., Rustamov, A., Özbek, L., Ferro, C. J., & Kanbay, M. (2025) · Clinical Transplantation · doi:10.1111/ctr.70384 · Cited by 1
Kounoue, N., Ochiai, S., Yazawa, M., Sofue, T., Fujii, N., Saitoh, M., Narita, I., Yamagata, K., Hoshino, J., & Oguchi, H. (2026) · Clinical and Experimental Nephrology · doi:10.1007/s10157-026-02836-7 · Cited by 1
Immunosuppressive Therapy in Kidney and Pancreas Transplantation
THOMAS, G. V., Nurko, S., & Srinivas, T. R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-642-9_3 · Cited by 1
Steroid withdrawal in renal transplant patients: the Irish experience
Phelan, P. J., Moran, A.-M., O’Kelly, P., Heng, P. Y., Yussof, S. M., Walshe, J. J., Magee, C., & Conlon, P. J. (2010) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-010-0626-8 · Cited by 1
Cardiovascular Diseases after Solid Organ Transplantation
Kim, J. (2011) · Korean Journal of Transplantation · doi:10.4285/jkstn.2011.25.4.229 · Cited by 1
New-onset diabetes after transplantation: focus on treatment strategies
Marino, A., Inankur, A., & Tannock, L. R. (2011) · Diabetes Management · doi:10.2217/dmt.11.33 · Cited by 1
Transplant surgery and the obese patient: special considerations
Srinivas, T. R., Mohan, P., & Kadian, M. (2015) · Transplant Research and Risk Management · doi:10.2147/trrm.s64014 · Cited by 1
Diabète secondaire aux traitements immunosuppresseurs en transplantation d'organe
Zuber, J., Pallet, N., Legendre, C., & Dubois‐Laforgue, D. (2010) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(10)53863-0 · Cited by 1
Immunosuppression for Kidney Transplantation
MacPhee, I. A. M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5547-8_70 · Cited by 1
Posttransplantation Diabetes Mellitus after Renal Transplantation – A Brief Overview
Kumar, E. P. (2019) · International Journal of Transplantation & Plastic Surgery · doi:10.23880/ijtps-16000s1-004 · Cited by 1
Nutrition in kidney transplant recipients to prevent downstream health issues
Paul, R., Hynes, M., & Lew, S. Q. (2019) · Journal of Kidney Care · doi:10.12968/jokc.2019.4.5.252 · Cited by 1
Cardiovascular Disease in Renal Transplantation
Lees, J. S., & Jardine, A. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53186-3.00030-9 · Cited by 1
Biomarkers of Kidney Injury and Rejection
O’Connell, P. J., Keung, K. L., Menon, M. C., & Murphy, B. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53186-3.00026-7 · Cited by 1
Current and Emerging Maintenance Immunosuppressive Therapy
Göral, S., & Helderman, J. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00036-4 · Cited by 1
Cardiovascular Disease in Renal Transplantation
McQuarrie, E. P., & Jardine, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4096-3.00030-1 · Cited by 1
A case of successful late steroid withdrawal after ABO-incompatible kidney transplantation
Cho, J. M., Jun, H., Jo, H. A., Han, K. H., Kim, H., & Han, S. Y. (2020) · Korean Journal of Transplantation · doi:10.4285/kjt.2020.34.2.121 · Cited by 1
Gilewski, W., Banach, J., Rogowicz, D., Wołowiec, Ł., Sielski, S., & Grześk, G. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001009 · Cited by 1
Kirnap, N. G., Kırnap, M., AlShalabi, O., Tütüncü, N. B., & Haberal, M. A. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.449 · Cited by 1
Gierczak, V., Noble, J., Malvezzi, P., Janbon, B., Terrec, F., Chevallier, E., Bennani, H. N., Bugnazet, M., Imerzoukene, F., Rostaing, L. P. E., et al. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.07.047 · Cited by 1
Adebiyi, O. O., Umukoro, P. E., Sharfuddin, A., Taber, T. E., Chen, J. M., Lane, K. A., Li, X., Goggins, W., & Yaqub, M. S. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.09.030 · Cited by 1
Transplantation: Kidney, Kidney–Pancreas Transplant
Zhang, R., & Paramesh, A. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_15 · Cited by 1
Immunosuppression in the Renal Transplant Recipient
Kennedy, C. M., & Magee, C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4454-1_35 · Cited by 1
Immunsuppression nach Nierentransplantation
Derad, I. (2021) · Springer eBooks · doi:10.1007/978-3-662-61492-1_30 · Cited by 1
Osteoporosis in Organ Transplant Patients
Stein, E. M., & Shane, E. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00056-x · Cited by 1
Post-transplant Diabetes Mellitus: What Physicians Need to Know
Etta, P. (2022) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0037 · Cited by 1
Sallaberger, S., Buchwinkler, L., Eder, S., Schneeberger, S., Mayer, G. J., & Pirklbauer, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247421 · Cited by 1
Immunosuppressive Therapy Following Renal Transplant: A Case Review
Wallinga, M. M., & Brody, R. A. (2025) · Topics in Clinical Nutrition · doi:10.1097/tin.0000000000000341 · Cited by 1
Risk Factors and Treatment Progress of Dyslipidemia after Kidney Transplantation
张, 克. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152460 · Cited by 1
Alemtuzumab in Kidney-Transplant Recipients
Luan, F. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1106937 · Cited by 1
Steroid Minimization in Kidney Transplantation: Longer Follow-Up Needed
Kamgar, M. K., & Bunnapradist, S. (2011) · Nephrology times · doi:10.1097/01.nep.0000398061.58169.eb · Cited by 1
Biological Agents in Kidney Transplantation
Huang, E., Womer, K. L., & Vincenti, F. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00035-2 · Cited by 1
Steroid Avoidance in Low-Immunologic Risk Kidney Transplant Recipients: The New Normal?
Legendre, C. M. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.12.016 · Cited by 1
Is it Time to Cut Down on Steroids?
Pondrom, S. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02547_1.x · Cited by 1
Mihovilović, K., Maksimović, B., Ljubanović, D. G., Vučur, K., & Knotek, M. (2025) · Research Square · doi:10.21203/rs.3.rs-7515781/v1 · Cited by 1
Cardiovascular Disease and Preventive Healthcare after Organ Transplantation
Pastan, S. O., & Gupta, D. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch88
Maintenance Immunosuppressive Therapy
Hardinger, K. L., Brennan, D. C., & Klein, C. L. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch66
Comparative Effectiveness in Transplantation
Meister, E. A., & Kaplan, B. E. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch135
Modern Immunosuppression Regimens in Kidney Transplantation
Afaneh, C. I., Meredith, J., & Kapur, S. (2012) · InTech eBooks · doi:10.5772/54092 · Cited by 1
Metabolic and Endocrine Management of the Organ Transplant Recipient
Issa, N. S., Reule, S. A., & Kukla, A. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch100
Current Status of Renal Transplantation
Rogers, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398523-1.00014-8
Glukokortikoidi v nefrologiji II: indikacije in odmerjanje
Pajek, J. (2015) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1237
Metadata
- Authors
- Woodle, E. S., First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., & Van Veldhuisen, P.
- Affiliations
- University of Cincinnati (US)
- Astellas Pharma (United States) (US)
- University of Wisconsin–Madison (US)
- University of Utah (US)
- Houston Methodist (US)
- Corresponding author
- Woodle, E Steve
- Venue
- Annals of Surgery
- Published
- 2008-10
- Volume
- 248
- Issue
- 4
- Pages
- 564-577
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2026860062
- Cited by
- 474
- References
- 29
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 8 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 24 · 2019: 26 · 2018: 22 · 2017: 25 · 2016: 32 · 2015: 26 · 2014: 45 · 2013: 29 · 2012: 43
- FWCI
- 29.87
- Type
- journal article
- Language
- en
- Open access
- green
- works.bepress.com
- Licence
- cc-by
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Journal of Bioresource Management (submittedVersion)
- Journal of Bioresource Management (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- corticosteroid withdrawal, kidney transplantation, prednisone, acute rejection, graft loss, patient death, antibody-mediated rejection, renal function, immunosuppression, delayed graft function, deceased donor, living donor, long-term outcomes, corticosteroid-sparing immunosuppression
- MeSH terms
- Adolescent, Adult, Aged, Biopsy, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Glucocorticoids, Graft Rejection, Humans, Kidney Failure, Chronic, Male, Middle Aged, Prednisone, Prospective Studies, Time Factors, Kidney Transplantation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.